SCHEMBL30775428

SCHEMBL30775428

Cc1cc(C)nc(OC2CCNCC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.43
IKBKB O14920 3/20 0.42
ROCK1 Q13464 3/20 0.39
CHUK O15111 2/20 0.39
LDHA P00338 1/20 0.39
TLR9 Q9NR96 2/20 0.38
TLR8 Q9NR97 2/20 0.38
TLR7 Q9NYK1 2/20 0.38
SYK P43405 2/20 0.38
P2RX7 Q99572 1/20 0.38
ROCK2 O75116 1/20 0.37
PRKACA P17612 1/20 0.37
PRKCD Q05655 1/20 0.37
PRKG1 Q13976 1/20 0.37
PKN1 Q16512 1/20 0.37
PKN2 Q16513 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
CDC42BPA Q5VT25 1/20 0.37
Q6ZSR9 Q6ZSR9 1/20 0.37
BMP2K Q9NSY1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21606919 0.81 HRH1 (0.52) HRH1IKBKBROCK1CHUKTLR9
SCHEMBL17123791 0.81 SLC6A2 (0.38) LDHASLC6A2SLC6A4
SCHEMBL21606923 0.81 ROCK1 (0.40) HRH1IKBKBROCK1CHUKTLR9
SCHEMBL21606997 0.81 SYK (0.44) HRH1IKBKBROCK1CHUKTLR9
SCHEMBL30422551 0.80 IRAK4 (0.49) HRH1IKBKBROCK1CHUKSYK
SCHEMBL29003898 0.80 IRAK4 (0.49) HRH1IKBKBROCK1CHUKSYK
Hydrochloric Acid SCHEMBL14861505 0.79 SLC6A2 (0.37) LDHASLC6A2SLC6A4
SCHEMBL21606922 0.77 HRH1 (0.44) HRH1IKBKBROCK1CHUKTLR9
SCHEMBL19755687 0.76 SLC6A2 (0.43) HRH1IKBKBROCK1CHUKSYK
SCHEMBL15360216 0.76 SYK (0.43) HRH1IKBKBROCK1CHUKTLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof DONG-A ST CO., LTD. (KR) 2025-03-04 US disclosed
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof EIF2AK4, GCN1, GCGR HRH1 2381/4885IKBKB 2417/4885ROCK1 1533/4885
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF EIF2AK4, GCN1, GCGR HRH1 2381/4885IKBKB 2417/4885ROCK1 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.